Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Soledad González-Muñiz"'
Autor:
Jesús Gutiérrez-Abril, Iñigo Santamaría, Ana S. Pitiot, Ana Gutiérrez-Fernández, Ángel Alvarez-Eguiluz, José M. Vicente, Carmen Sanzo, Soledad González-Muñiz, Milagros Balbín, Xose S. Puente
Publikováno v:
Haematologica, Vol 102, Iss 12 (2017)
Externí odkaz:
https://doaj.org/article/0f2b5d7a763d4f18b570b3d0a351eb7b
Autor:
Aránzazu López Martínez, Marta Suárez González, Begoña Menéndez Llames, Pilar Palomo Moraleda, Soledad González Muñiz, Juan José Díaz Martín
Publikováno v:
Nutricion hospitalaria. 39(5)
Material and methods: a retrospective study of childhood acute leukemia survivors. Survivors with a diagnosis of leukemia before 16 years of age in a tertiary hospital, during the period of 1998-2018, were selected, who had completed their treatment
Autor:
Laurent Garderet, Meral Beksac, Cecilia Isaksson, Stig Lenhoff, Xavier Poiré, Alina Tanase, Giulia Sbianchi, Soledad González Muñiz, Jenny Byrne, Jane F. Apperley, Paul Browne, Linda Koster, Simona Iacobelli, Arnon Nagler, Ibrahim Yakoub-Agha, Jiri Mayer, Cyrille Touzeau, Marek Trneny, Rocio Parody Porras, Grzegorz W. Basak, Patrick Hayden, Didier Blaise, Mariagrazia Michieli, Péter Reményi, Stefan Schönland
Publikováno v:
European journal of haematology, Vol. 106, no.5, p. 708-715 (2021)
Background In autologous stem cell transplant (ASCT)-eligible myeloma patients, prolonged induction does not necessarily improve the depth of response. Method We analysed 1,222 ASCT patients who were classified based on (1) the interval between induc
Autor:
Grzegorz W. Basak, Jiri Mayer, Soledad González Muñiz, Paul Bosman, Giulia Sbianchi, Johan Lund, Jane F. Apperley, Guido Kobbe, Stig Lenhoff, Sarah Lawless, Curly Morris, Cecilia Isaksson, Esa Jantunen, Achilles Anagnostopoulos, Paul Browne, Jennifer Byrne, Didier Blaise, Simona Iacobelli, Alessandro Rambaldi, Ibrahim Yakoub-Agha, Péter Reményi, Nicolaas Schaap, Keith M.O. Wilson, Stefan Schönland, Nicolaus Kröger, Christof Scheid, Cyrille Touzeau, Laurent Garderet
Publikováno v:
Clinical Lymphoma Myeloma & Leukemia, 21, 686-693
Clinical Lymphoma, Myeloma and Leukemia, 21(10), 686-693. CIG MEDIA GROUP, LP
Clinical Lymphoma Myeloma & Leukemia, 21, 10, pp. 686-693
Clinical Lymphoma, Myeloma and Leukemia, 21(10), 686-693. CIG MEDIA GROUP, LP
Clinical Lymphoma Myeloma & Leukemia, 21, 10, pp. 686-693
The rare myelomas, immunoglobulin (Ig)D, IgM, and non-secretory, have been associated with poorer outcomes following treatment than the common myelomas (IgG, IgA, and light-chain only). We show that even with "novel" therapies, augmented with autolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c144cc4a414ce17f2a367c91656e25de
https://hdl.handle.net/1887/3281911
https://hdl.handle.net/1887/3281911
Autor:
Carlo Dufour, Daria Pagliara, Selim Corbacioglu, Jean Hugues Dalle, Josune Zubicaray, Julián Sevilla, Paola Corti, Franca Fagioli, Marco Zecca, Régis Peffault de Latour, Dirk Jan Eikema, Akif Yeşilipek, Gergely Kriván, Paul Bosman, Manuel Abecasis, Antonio M. Risitano, Savaş Kansoy, Maura Faraci, Andrea Velardi, Soledad González Muñiz, Alphan Kupesiz, Mouhab Ayas, Cecile Renard, Antonio Campos, Frans J. Smiers
Publikováno v:
American Journal of Hematology, 96(5), 571-579. WILEY
Allogeneic hematopoietic cell transplantation (HCT) is the only curative option for bone marrow failure or hematopoietic malignant diseases for Fanconi anemia (FA) patients. Although results have improved over the last decades, reaching more than 90%
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0af6c416d4881bb88dfe2a07feb5af45
https://hdl.handle.net/1887/3281910
https://hdl.handle.net/1887/3281910
Autor:
Didier Blaise, Soledad González Muñiz, Jane F. Apperley, Nicolaus Kröger, Péter Reményi, Nicolaas Schaap, Firoozeh Sahebi, Stig Lenhoff, Ibrahim Yakoub-Agha, Marta Krejčí, Nigel H. Russell, Giulia Sbianchi, Marek Trneny, Guido Kobbe, Wieslaw Wiktor-Jedrzejczak, Cecilia Isaksson, Christof Scheid, Stefan Schönland, Laurent Garderet, Curly Morris, Per Ljungman, Paul Browne, Linda Koster, Simona Iacobelli, James F. Sanchez, Keith Wilson
Publikováno v:
Biology of Blood and Marrow Transplantation, 24, 930-936
Biology of Blood and Marrow Transplantation, 24, 5, pp. 930-936
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (5), pp.930-936. ⟨10.1016/j.bbmt.2018.01.006⟩
Biology of Blood and Marrow Transplantation, 24, 5, pp. 930-936
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (5), pp.930-936. ⟨10.1016/j.bbmt.2018.01.006⟩
The advent of novel agents for multiple myeloma (MM) is cause for a re-examination of the incidence of second primary malignancies (SPM5). We examined the SPM rate in MM patients who were enrolled in the prospective observational CALM (Collaboration
Autor:
Ana Gutiérrez-Fernández, Jesús Gutiérrez-Abril, Ana S. Pitiot, Ángel Alvarez-Eguiluz, Íñigo Santamaría, Milagros Balbín, Soledad González-Muñiz, Carmen Sanzo, Xose S. Puente, Jose Maria Vicente
Publikováno v:
Scopus
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
This work was funded by the Spanish Ministry of Economy and Competitiveness (grant SAF2013-45836-R). J.G-A. is supported by a fellowship from the Spanish Ministry of Education. We thank Fundación Caja Rural de Asturias for financial collaborative su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8a8394c66dfd947ff4436ab0a25368a
http://hdl.handle.net/10651/46081
http://hdl.handle.net/10651/46081
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.